|transkript in its 28th year

|transkript, one of our German magazines, has been the leading industry publication for biotechnology and life sciences in German-speaking Europe since 1995. It covers current information, opinions, and background on business, research, and politics. In this issue:

Berlin, 10/02/2022 – European investment managers have raised billions and are now on the hunt for the next BioNTech. However, the topic of ageing is also attracting investors, as highlighted in the interview with Dr Marianne Mertens from Apollo Health Ventures. Germany’s biotech sector is looking ahead to 2022 with optimism, according to BIO Deutschland’s traditional annual survey. The industry is also quietly anticipating the Swiss Biotech Day and the AMR Conference in Basel. These and other topics can be found in the first issue of the 28th volume of |transkript.

Other topics in this issue:

• |transkript special on the DACH region as a production hub
• Lab World special on automation
• Medtechzwo focusing on digital health and artificial intelligence